Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | IL-13 | 59.0 | 63 | |
N2586 | PI103 | 0.1 | uM | 3 | IL-13 | 42.5 | 66 | ||||
0 | IL-13 | 17.0 | 50 | ||||||||
RA2159 | TNF-a | 100 | ng/mL | 3 | IL-13 | 48.5 | 62 | ||||
RA2159 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 90.0 | 49 | |
RA2159 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 47.0 | 69 | |
RA2159 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 61.0 | 65 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 46.0 | 59 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 51.0 | 53 | |
RA2159 | EO1428 | 1.0 | uM | 3 | IL-13 | 36.0 | 51 | ||||
N2586 | TNF-a | 100 | ng/mL | 3 | IL-13 | 49.5 | 66 | ||||
N2586 | PD184352 | 0.1 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 48.0 | 49 | |
N2586 | Lestaurtinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 52.5 | 64 | |
N2586 | Ruxolitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 38.0 | 55 | |
N2586 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 71.0 | 57 | |
N2586 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 3 | IL-13 | 65.5 | 72 | |
N2586 | EO1428 | 1.0 | uM | 3 | IL-13 | 52.5 | 64 | ||||
0 | IL-13 | 14.0 | 53 | ||||||||
RA2159 | 3 | IL-13 | 39.5 | 58 | |||||||
RA2159 | PD184352 | 0.1 | uM | 3 | IL-13 | 62.0 | 60 | ||||
RA2159 | Lestaurtinib | 0.3 | uM | 3 | IL-13 | 35.0 | 74 | ||||
RA2159 | Ruxolitinib | 0.3 | uM | 3 | IL-13 | 49.0 | 75 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 3 | IL-13 | 35.5 | 34 | ||||
RA2159 | IKK16 | 2.0 | uM | 3 | IL-13 | 28.0 | 57 | ||||
RA2159 | 3 | IL-13 | 39.0 | 67 |